Zherui Shen

595 total citations
24 papers, 419 citations indexed

About

Zherui Shen is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zherui Shen has authored 24 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Genetics and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zherui Shen's work include Heme Oxygenase-1 and Carbon Monoxide (12 papers), High Altitude and Hypoxia (9 papers) and Inflammasome and immune disorders (7 papers). Zherui Shen is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (12 papers), High Altitude and Hypoxia (9 papers) and Inflammasome and immune disorders (7 papers). Zherui Shen collaborates with scholars based in China, Switzerland and United States. Zherui Shen's co-authors include Demei Huang, Yilan Wang, Shihua Shi, Caixia Pei, Yongcan Wu, Zhenxing Wang, Yacong He, Fei Wang, Xiaomin Wang and Xiaoming Wang and has published in prestigious journals such as Frontiers in Microbiology, Biochemical Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

Zherui Shen

21 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zherui Shen China	13	251	175	97	61	56	24	419
Shu-Dong Qiu China	12	197 0.8×	86 0.5×	57 0.6×	105 1.7×	81 1.4×	23	489
Xiaomei Zhang China	16	175 0.7×	133 0.8×	66 0.7×	21 0.3×	24 0.4×	35	477
Ya‐Lin Jiang China	10	163 0.6×	76 0.4×	36 0.4×	27 0.4×	30 0.5×	21	288
Xichen Wang China	11	120 0.5×	51 0.3×	57 0.6×	15 0.2×	71 1.3×	40	418
Xiaomin Dang China	10	280 1.1×	111 0.6×	179 1.8×	8 0.1×	31 0.6×	16	481
Mohammad A. BaSalamah Saudi Arabia	13	130 0.5×	34 0.2×	48 0.5×	63 1.0×	102 1.8×	22	486
Neil J. Kelly United States	9	201 0.8×	167 1.0×	43 0.4×	15 0.2×	24 0.4×	20	481
I Made Winarsa Ruma Indonesia	10	199 0.8×	50 0.3×	51 0.5×	20 0.3×	19 0.3×	25	342
Thierry Ntimbane Canada	9	231 0.9×	137 0.8×	110 1.1×	25 0.4×	12 0.2×	10	567
Mitsuya Ito Japan	11	146 0.6×	70 0.4×	88 0.9×	29 0.5×	13 0.2×	37	450

Countries citing papers authored by Zherui Shen

Since Specialization

Citations

This map shows the geographic impact of Zherui Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zherui Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zherui Shen more than expected).

Fields of papers citing papers by Zherui Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zherui Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zherui Shen. The network helps show where Zherui Shen may publish in the future.

Co-authorship network of co-authors of Zherui Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Zherui Shen. A scholar is included among the top collaborators of Zherui Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zherui Shen. Zherui Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Zherui, et al.. (2026). Neuroimmune circuits in respiratory pathophysiology: decoding molecular crosstalk for precision therapeutic targeting. Annals of Medicine. 58(1). 2620337–2620337.

Chen, Qian, Demei Huang, Junling Liu, et al.. (2025). The gut microbiota in high-altitude medicine: intersection of hypoxic adaptation and disease management. Frontiers in Microbiology. 16. 1705487–1705487.

Shen, Zherui, Qian Chen, Chen Chen, et al.. (2025). Astragaloside II pretreatment alleviates PM2.5-induced lung injury in mice via MAPK/Nrf2/GPX4 axis-mediated suppression of ferroptosis. Ecotoxicology and Environmental Safety. 302. 118613–118613.

He, Yacong, Huxinyue Duan, Demei Huang, et al.. (2025). Pharmacological targeting of ferroptosis in hypoxia-induced pulmonary edema: therapeutic potential of ginsenoside Rg3 through activation of the PI3K/AKT pathway. Frontiers in Pharmacology. 16. 1644436–1644436. 1 indexed citations

Wang, Yilan, Ying Liu, Caixia Pei, et al.. (2024). Notoginsenoside R1 treatment facilitated Nrf2 nuclear translocation to suppress ferroptosis via Keap1/Nrf2 signaling pathway to alleviated high-altitude myocardial injury. Biomedicine & Pharmacotherapy. 175. 116793–116793. 13 indexed citations

Huang, Demei, Yilan Wang, Caixia Pei, et al.. (2024). Pre-treatment with notoginsenoside R1 from Panax notoginseng protects against high-altitude-induced pulmonary edema by inhibiting pyroptosis through the NLRP3/caspase-1/GSDMD pathway. Biomedicine & Pharmacotherapy. 180. 117512–117512. 6 indexed citations

Liu, Junling, Caixia Pei, Zherui Shen, et al.. (2024). Preconditioning with Ginsenoside Rg3 mitigates cardiac injury induced by high-altitude hypobaric hypoxia exposure in mice by suppressing ferroptosis through inhibition of the RhoA/ROCK signaling pathway. Journal of Ethnopharmacology. 337(Pt 2). 118861–118861. 11 indexed citations

Pei, Caixia, Zherui Shen, Yongcan Wu, et al.. (2024). Eleutheroside B Pretreatment Attenuates Hypobaric Hypoxia‐Induced High‐Altitude Pulmonary Edema by Regulating Autophagic Flux via the AMPK/mTOR Pathway. Phytotherapy Research. 38(12). 5657–5671. 2 indexed citations

Huang, Demei, Zherui Shen, Caixia Pei, et al.. (2023). Sipeimine attenuates PM2.5-induced lung toxicity via suppression of NLRP3 inflammasome-mediated pyroptosis through activation of the PI3K/AKT pathway. Chemico-Biological Interactions. 376. 110448–110448. 14 indexed citations

10.

Pei, Caixia, Yilan Wang, Zherui Shen, et al.. (2023). Notoginsenoside R1 protects against hypobaric hypoxia-induced high-altitude pulmonary edema by inhibiting apoptosis via ERK1/2-P90rsk-BAD ignaling pathway. European Journal of Pharmacology. 959. 176065–176065. 12 indexed citations

11.

Huang, Demei, Caixia Pei, Zherui Shen, et al.. (2023). Rosavidin protects against PM2.5-induced lung toxicity via inhibition of NLRP3 inflammasome-mediated pyroptosis by activating the PI3K/AKT pathway. Biochemical Pharmacology. 213. 115623–115623. 8 indexed citations

12.

Shi, Shihua, Demei Huang, Yongcan Wu, et al.. (2023). Salidroside pretreatment alleviates PM2.5 caused lung injury via inhibition of apoptosis and pyroptosis through regulating NLRP3 Inflammasome. Food and Chemical Toxicology. 177. 113858–113858. 17 indexed citations

13.

Shen, Zherui, Demei Huang, Caixia Pei, et al.. (2023). Protective effects of Eleutheroside E against high-altitude pulmonary edema by inhibiting NLRP3 inflammasome-mediated pyroptosis. Biomedicine & Pharmacotherapy. 167. 115607–115607. 13 indexed citations

14.

Shen, Zherui, Yilan Wang, Caixia Pei, et al.. (2023). Eleutheroside E from pre-treatment of Acanthopanax senticosus (Rupr.etMaxim.) Harms ameliorates high-altitude-induced heart injury by regulating NLRP3 inflammasome-mediated pyroptosis via NLRP3/caspase-1 pathway. International Immunopharmacology. 121. 110423–110423. 17 indexed citations

15.

Wang, Yilan, Zherui Shen, Demei Huang, et al.. (2022). Sipeimine ameliorates PM2.5-induced lung injury by inhibiting ferroptosis via the PI3K/Akt/Nrf2 pathway: A network pharmacology approach. Ecotoxicology and Environmental Safety. 239. 113615–113615. 53 indexed citations

16.

Huang, Demei, Shihua Shi, Yilan Wang, et al.. (2022). Astragaloside IV alleviates PM2.5-caused lung toxicity by inhibiting inflammasome‐mediated pyroptosis via NLRP3/caspase-1 axis inhibition in mice. Biomedicine & Pharmacotherapy. 150. 112978–112978. 28 indexed citations

17.

Wang, Xiaoming, Yilan Wang, Demei Huang, et al.. (2022). Astragaloside IV regulates the ferroptosis signaling pathway via the Nrf2/SLC7A11/GPX4 axis to inhibit PM2.5-mediated lung injury in mice. International Immunopharmacology. 112. 109186–109186. 106 indexed citations

18.

Wang, Yilan, Zherui Shen, Demei Huang, et al.. (2022). Pretreatment with rosavin attenuates PM2.5‐induced lung injury in rats through antiferroptosis via PI3K/Akt/Nrf2 signaling pathway. Phytotherapy Research. 37(1). 195–210. 30 indexed citations

19.

Wu, Yongcan, Caixia Pei, Xiaomin Wang, et al.. (2022). Probiotics ameliorates pulmonary inflammation via modulating gut microbiota and rectifying Th17/Treg imbalance in a rat model of PM2.5 induced lung injury. Ecotoxicology and Environmental Safety. 244. 114060–114060. 33 indexed citations

20.

Shi, Shihua, Fei Wang, Bonan Chen, et al.. (2022). Efficacy and Safety of Shenfu Injection for Severe Pneumonia in the Elderly: A Systematic Review and Meta-Analysis Based on Western and Eastern Medicine. Frontiers in Pharmacology. 13. 779942–779942. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact